Multimorbidity Management Supported by a Digital Platform

Summary

This study aims to assess whether the use of the METHIS digital platform using a patient-centered approach contributes to an improvement in the quality of life, mental health and physical activity of patients with multimorbidity followed up in Primary Health Care. Practices will be randomly allocated between: providing access to consultations through the METHIS platform (intervention) or following patients by the traditional method (control). They will complete questionnaires on quality of life, mental health and report the number of steps taken, at the beginning and end of the study.

Conditions

• Chronic Disease

Interventions

DEVICE

METHIS Platform

The METHIS platform is a digital healthcare platform, supported by three databases using PostreSQL (based in relational SQL). One of the databases allows adequate internal testing before production. Another database of production (secured with unique access codes) will be created to retrieve data from the practices' and the last database for the research data, where pseudonymised production data can be analysed for research purposes. The platform is integrated (via FCCN Scientific Computation Unit of the Portuguese Fundação para a Ciência e a Tecnologia) with the Software Zoom® to allow encrypted teleconsultations, with a guarantee that each patient connection is unique. The digital platform is web-based, and it can be used in multiple devices.

OTHER

Goal-Oriented Care Training Program

The training program will have three stages: initial face-to-face training, which will happen before the data collection, followed by remote, asynchronous training during a 12-month period, and a final seminar to discuss the results and inquire about the usability of the GOC model and the METHIS platform. The course will be offered to the intervention group one month before the start of patient recruitment, and for the control group at least one month after the end of data collection.

Sponsors & Collaborators

• Administração Regional de Saúde de Lisboa e Vale do Tejo, Portugal

  collaborator UNKNOWN

• Universidade Lusófona de Humanidades e Tecnologias

  collaborator OTHER

• NOVA Medical School

  collaborator OTHER

• NOVA School of Science and Technology ı FCT NOVA

  collaborator OTHER

• University Hospital, Geneva

  collaborator OTHER

• Universidade Nova de Lisboa

  lead OTHER

Principal Investigators

• Luís V. Lapão, PhD · Universidade Nova de Lisboa

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

50 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-06-01

Primary Completion

2026-01-30

Completion

2027-05-31